Throughout all of our columns, we’ve provided succinct overviews of critical components of new ventures in ophthalmology—including defining a target product profile; considerations around raising money; building an intellectual property (IP) estate; and when to explore conducting an ex-U.S. trial. In this installment, we will build off of these topics by discussing the value of regional strategic partnerships and licensing. These partnerships can provide significant benefits to ophthalmic entrepreneurs’ programs via additional capital, resources, conduct of activities to help move a program forward and/or credibility. Through this brief column, we hope that you’ll continue to glean a few insights that may help your ophthalmic program best navigate early stage business planning and development, to bridge the valley of death and reach value inflection, as well as increase the overall value of your program. –Matthew Chapin, Aki Tobaru and Van Sandwick • Ora Inc., Andover, Mass.
Posted on: Tue, 14 Oct 2014 13:35:00 +0000
Trending Topics
Recently Viewed Topics
© 2015